SAP News

Heidi D. Finnes, PharmD, BCOP, FHOPA, president-elect of Hematology/Oncology Pharmacy Association (HOPA), provides details of the upcoming HOPA 2022 conference.

Heidi D. Finnes, PharmD, BCOP, FHOPA, president-elect of Hematology/Oncology Pharmacy Association (HOPA), provides details of the upcoming HOPA 2022 conference.

Larry Buie, PharmD, BCOP, FASHP, outgoing president of the Hematology/Oncology Pharmacy Association (HOPA), shares some details of HOPA’s upcoming 2022 annual conference in Boston and provides an overview of his term as HOPA’s president.

Pharmacy Times will be covering the upcoming Hematology and Oncology Pharmacy Association (HOPA) Association Annual Conference live in Boston, Massachusetts, taking place March 30 through April 2.

Seven custom measures receive approval, raising the bar on oncology patient care.

NPC announced the appointment of Sharon Phares, PhD, MPH, as Chief Scientific Officer.

The unique challenges that pharmacy learners encountered during the COVID-19 pandemic reinforce their importance in the professional pharmacy setting.

CTCA leverages new CMS Conditions of Participation notification requirements as opportunity for innovation.

Cheryl Larson, president and CEO of Midwest Business Group on Health, discusses current efforts to manage drug spend and the high cost of specialty drugs on the market.

Antonio Ciaccia, CEO of 46brooklyn Research, discusses his company’s efforts to uncover and understand the structure that underlies US drug pricing distortions.

Sarah Cannon and Pontchartrain Cancer Center will join the esteemed program.

Pharmacy Times® announces the addition of six new partners to its Strategic Alliance Partnership program.

The ASCO-COA Oncology Medical Home standards offer a roadmap for comprehensive high-quality, patient-centered cancer care delivery.

Kirollos Hanna, PharmD, BCPS, BCOP, assistant professor of pharmacy at the Mayo Clinic College of Medicine and the oncology pharmacy manager at M Health Fairview - Maple Grove, discusses the potential impact of ACCC's Multiple Myeloma Dispensing Project on the field.

American Oncology Network, LLC in-house specialty pharmacy is pleased to announce that it has successfully completed reaccreditation through Accreditation Commission for Health Care for specialty pharmacy services.

The "human first" health company is the first virtual specialized care company to partner with the publication.

NPC's new president and CEO outlines his commitment to working with all partners, across all sectors, to improve our health care system.

The collaborative effort by pharmacies, which include Walgreens, CVS, and Albertsons Company stores, is part of the National Month of Action for COVID-19 vaccinations.

Over 80% of non-small cell lung cancer detected at stage 4.

Key highlights include a plenary session on cervical cancer among women in developing nations and an oral abstract exploring molecular testing and targeted therapy for metastatic non-small cell lung cancer, among other topics.

Mathew Reynolds, PhD, IQIVA, vice president of real-world evidence at IQVIA, discussed how the COVID-19 pandemic has affected regular health screenings, mail-order dispensing, and home infusions.

Kenneth Komorny, PharmD, BCPS, a co-lead on development of National Comprehensive Cancer Network recommendations for biosimilar management, explains some of the positions the NCCN has taken.